Erich Bam

Chief Operating Officer at ViRexx Medical Corp.

Consumer Services

Health Technology

Profile

Erich Bam is currently the Chief Operating Officer at ViRexx Medical Corp.
He has a graduate degree from the University of South Africa and an undergraduate degree from the University of Stellenbosch.

Erich Bam active positions

Companies	Position	Start
ViRexx Medical Corp. ViRexx Medical Corp. Pharmaceuticals: MajorHealth Technology ViRexx Medical Corp. engages in the research, development, and commercialization of biopharmaceutical products for the treatment of cancer and chronic viral infections. It provides drugs for the treatment of ovarian cancer, chronic hepatitis B, hepatitis C and selected solid tumors. It has three platform technologies: The Antiboby-based immunotherapy and Chimigen platforms are designed to educate the immune system to recognize and remove cancer and chronic viruses in the body. The Targeted-Autothrombogenic cancer therapy platform is designed to cut off the blood supply to tumors, which leads to tumor tissue starvation and death. The company is headquartered in Edmonton, Canada.	Chief Operating Officer	12/10/2007

All active positions of Erich Bam

Training of Erich Bam

University of Stellenbosch	Undergraduate Degree
University of South Africa	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Erich Bam's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
ViRexx Medical Corp. ViRexx Medical Corp. Pharmaceuticals: MajorHealth Technology ViRexx Medical Corp. engages in the research, development, and commercialization of biopharmaceutical products for the treatment of cancer and chronic viral infections. It provides drugs for the treatment of ovarian cancer, chronic hepatitis B, hepatitis C and selected solid tumors. It has three platform technologies: The Antiboby-based immunotherapy and Chimigen platforms are designed to educate the immune system to recognize and remove cancer and chronic viruses in the body. The Targeted-Autothrombogenic cancer therapy platform is designed to cut off the blood supply to tumors, which leads to tumor tissue starvation and death. The company is headquartered in Edmonton, Canada.	Health Technology